Biofilm: its relevance in kidney disease

Area of Science:

• Microbiology
• Biomedical Engineering
• Infectious Diseases

Background:

• Biofilms are complex microbial communities encased in an exopolysaccharide matrix, contributing to persistent infections, inflammation, and tissue damage.
• In chronic kidney disease (CKD) patients, biofilms are implicated beyond hemodialysis circuits, potentially exacerbating cardiovascular risk and chronic inflammation.
• Current antimicrobial strategies often fail to target sessile biofilm forms, which act as reservoirs for planktonic bacteria.

Purpose of the Study:

• To highlight the multifaceted impact of biofilms in medical settings, particularly in chronic kidney disease patients.
• To discuss the limitations of current anti-infective strategies against biofilms.
• To explore emerging and preventative approaches for managing biofilm-related infections.

Main Methods:

• Literature review and synthesis of current research on biofilm formation, medical implications, and treatment strategies.
• Analysis of the role of biofilms in chronic kidney disease and associated complications.
• Evaluation of novel therapeutic approaches including molecular blockading, electrical enhancement, and bacterial interference.

Main Results:

• Biofilm formation leads to severe health consequences, including chronic infections and increased cardiovascular risk in CKD patients.
• Existing treatments are often ineffective against mature biofilms, necessitating new therapeutic targets.
• Emerging strategies show promise, but prevention of initial microbial colonization remains the most effective approach.

Conclusions:

• Biofilms represent a significant challenge in healthcare, demanding targeted strategies for eradication and prevention.
• Preventing microbial colonization through meticulous sterile handling of medical devices is paramount.
• Future research should focus on developing therapies that eradicate established biofilms and prevent their formation.